Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
32.20
+0.22 (0.69%)
Nov 22, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$41.17
Upside
+27.86%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Buy Initiates $45 | Buy | Initiates | $45 | +39.75% | Nov 22, 2024 |
Wedbush | Wedbush | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +39.75% | Nov 8, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | +58.39% | Oct 11, 2024 |
RBC Capital | RBC Capital | Buy Maintains $32 → $42 | Buy | Maintains | $32 → $42 | +30.43% | Sep 20, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 → $33 | Strong Buy | Maintains | $25 → $33 | +2.48% | Sep 19, 2024 |
RBC Capital | RBC Capital | Buy Maintains $32 | Buy | Maintains | $32 | -0.62% | Sep 17, 2024 |
Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | -3.73% | Aug 16, 2024 |
JP Morgan | JP Morgan | Buy Maintains $30 → $31 | Buy | Maintains | $30 → $31 | -3.73% | Aug 12, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $32 | Buy | Reiterates | $32 | -0.62% | Jul 25, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $32 | Buy | Reiterates | $32 | -0.62% | Jul 10, 2024 |
JP Morgan | JP Morgan | Buy Maintains $27 → $30 | Buy | Maintains | $27 → $30 | -6.83% | Jul 9, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $48 | Buy | Maintains | $48 | +49.07% | Jul 1, 2024 |
Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | -3.73% | Jun 26, 2024 |
RBC Capital | RBC Capital | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | -0.62% | Apr 22, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | -22.36% | Apr 17, 2024 |
Wedbush | Wedbush | Buy Reiterates $26 | Buy | Reiterates | $26 | -19.25% | Apr 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.